Laurus Labs Q2 FY27 consolidated revenue Rs 2,206.37 cr, PAT Rs 436.74 cr
For the quarter ended 30-Sep-26, Laurus Labs’ consolidated revenue from operations was Rs 2,206.37 cr and net profit after tax Rs 436.74 cr, up from Rs 1,653.47 cr and Rs 193.75 cr a year earlier.
Key takeaways
- Revenue from operations Rs 2,206.37 cr vs Rs 1,653.47 cr in the quarter ended 30-Sep-25
- Total income Rs 2,219.38 cr vs Rs 1,680.43 cr in the corresponding prior quarter
- Total expenses Rs 1,627.56 cr vs Rs 1,410.70 cr a year earlier
- Profit before tax Rs 591.82 cr vs Rs 269.73 cr in the quarter ended 30-Sep-25
- Net Profit after tax Rs 436.74 cr vs Rs 193.75 cr; basic EPS Rs 8.17 vs Rs 3.61
Q2 FY27 · consolidated
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 2,206.37 cr | Rs 1,653.47 cr | +33.5% |
| PAT | Rs 436.74 cr | Rs 193.75 cr | +125.4% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 19.79% of revenue, up 807 bps from 11.72%.
- Revenue rose 33.4% while total expenses rose 15.4%.
• Revenue from operations (Q2 FY27, consolidated): Rs 2,206.37 cr vs Rs 1,653.47 cr in the quarter ended 30-Sep-25
• Other income: Rs 13.01 cr vs Rs 26.96 cr
• Total income: Rs 2,219.38 cr vs Rs 1,680.43 cr
• Cost of materials consumed: Rs 900.69 cr vs Rs 676.75 cr
• Purchase of traded goods: Rs 45.01 cr vs Rs 30.70 cr
• Changes in inventories of finished goods, work-in-progress and stock-in-trade: Rs (129.61) cr vs Rs (44.01) cr
• Employee benefits expense: Rs 265.71 cr vs Rs 215.56 cr
• Other expenses: Rs 374.27 cr vs Rs 371.21 cr
• Depreciation and amortisation expense: Rs 127.39 cr vs Rs 120.49 cr
• Finance costs: Rs 44.10 cr vs Rs 40.00 cr
• Total expenses: Rs 1,627.56 cr vs Rs 1,410.70 cr
• Profit before tax: Rs 591.82 cr vs Rs 269.73 cr
• Total tax expense: Rs 155.08 cr vs Rs 75.98 cr
• Net Profit after tax: Rs 436.74 cr vs Rs 193.75 cr
• Earnings per equity share – Basic: Rs 8.17 vs Rs 3.61
• Earnings per equity share – Diluted: Rs 8.16 vs Rs 3.61
According to the statement of consolidated unaudited financial results for the quarter ended 30-Sep-26, Laurus Labs reported higher revenue from operations of Rs 2,206.37 cr compared with Rs 1,653.47 cr in the corresponding quarter ended 30-Sep-25. Total income rose to Rs 2,219.38 cr from Rs 1,680.43 cr over the same period.
On the cost side, cost of materials consumed increased to Rs 900.69 cr from Rs 676.75 cr, while purchase of traded goods was Rs 45.01 cr versus Rs 30.70 cr a year earlier. Changes in inventories of finished goods, work-in-progress and stock-in-trade stood at Rs (129.61) cr compared with Rs (44.01) cr. Employee benefits expense rose to Rs 265.71 cr from Rs 215.56 cr, and other expenses were Rs 374.27 cr versus Rs 371.21 cr. Depreciation and amortisation expense was Rs 127.39 cr compared with Rs 120.49 cr, and finance costs were Rs 44.10 cr versus Rs 40.00 cr in the corresponding prior quarter.
Total expenses for the quarter came in at Rs 1,627.56 cr against Rs 1,410.70 cr a year earlier. Profit before tax increased to Rs 591.82 cr from Rs 269.73 cr. Total tax expense (current and deferred) was Rs 155.08 cr compared with Rs 75.98 cr in the quarter ended 30-Sep-25. Net profit after tax for the quarter was Rs 436.74 cr, up from Rs 193.75 cr. Basic earnings per equity share (face value Rs 2 each) were reported at Rs 8.17 versus Rs 3.61, and diluted earnings per share were Rs 8.16 versus Rs 3.61, as per the statement of financial results.
Track Laurus Labs Ltd
Cruxal reads every Laurus Labs Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.